Company: NCNO
Filing Date: 2025-12-03
Form Type: 10-Q
Source: 0001902733-25-000131
Chunk: 74

Company: nCino, Inc.
Filing Date: 2025-12-03
Form: 10-Q
Item: Part I, Item 1
Chunk 74
---
540 Effect of diluted stock options, unvested RSUs, and shares of common stock issuable under the ESPP— 1,422,788 — — Weighted-average common shares outstanding, diluted115,611,833 115,830,218 114,970,622 113,594,540 Diluted net income (loss) per share attributable to nCino, Inc.$(0.05)$0.06 $(0.17)$(0.03)The following potential outstanding common stock were excluded from the diluted net income (loss) per share computation because the effect would have been anti-dilutive:Nine Months Ended October 31,20242025Stock options issued and outstanding920,412 535,929 Nonvested RSUs issued and outstanding6,367,467 6,770,521 Shares issuable pursuant to the ESPP77,914 88,428 

28

Table of ContentsnCino, Inc.NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(In thousands, except share and per share amounts and unless otherwise indicated)

Note 14. Segment Information

The Company’s chief operating decision maker (“CODM”) is the Company’s Chief Executive Officer, who reviews financial information on a consolidated basis. The Company brings together people and data to enable financial institutions to enhance strategic decision-making, risk management, and customer satisfaction through the selection of intelligent solutions provided by the nCino Platform as a SaaS company. As such, the Company has one operating and reportable segment. The CODM uses consolidated net income (loss) in deciding how to make operating decisions, allocate resources, and assess performance, including whether to reinvest profits into the existing business or to use in other ways, such as for acquisitions.The following table presents selected financial information that is provided to our CODM:Three Months Ended October 31,Nine Months Ended October 31,2024202520242025Revenues$138,797 $152,163 $399,287 $445,115 Less:Adjusted cost of revenues(1)45,586 49,332 134,896 148,581 Adjusted sales and marketing expense(1)22,464 24,984 68,738 78,753 Adjusted research and development expense(1)28,831 25,211 83,571 80,937 Adjusted general and administrative expense(1)